Skip to main content

Table 2 Etiological (inherited) profile of the study group

From: Clinical outcomes of submassive pulmonary embolism thrombolysis—an Indian experience

  Control group Thrombolysis group p value
Factor V Leiden 2 (4.5) 2 (4.8) 0.962
Prothrombin gene mutation 0 (0) 0 (0)
Anti-thrombin III deficiency 0 (0) 0 (0)
Protein C deficiency 0 (0) 1 (2.4) 0.303
Protein S deficiency 0 (0) 3 (7.1) 0.071
ANA/APLA 4 (9.1) 3 (7.1) 0.741
Homocysteinemia 1 (2.3) 3 (7.1) 1.149
JAK2 0 (0) 2 (4.8) 0.143
  1. p value < 0.05, statistically significant. ANA antinuclear antibody, APLA antiphospholipid antibody syndrome